These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2947253)

  • 21. Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555.
    Upton R; Widdowson PS; Ishii S; Tanaka H; Williams G
    Br J Pharmacol; 1998 Dec; 125(8):1708-14. PubMed ID: 9886762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diazoxide enhances basal metabolic rate and fat oxidation in obese Zucker rats.
    Alemzadeh R; Karlstad MD; Tushaus K; Buchholz M
    Metabolism; 2008 Nov; 57(11):1597-607. PubMed ID: 18940400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction of hyperinsulinemia and insulin resistance by opiate receptor blockade in the polycystic ovary syndrome with acanthosis nigricans.
    Givens JR; Kurtz BR; Kitabchi AE; Bittle JB; Karas JG; Mitchell JA; Howes JF
    J Clin Endocrinol Metab; 1987 Feb; 64(2):377-82. PubMed ID: 3539980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute stimulation of feeding with repeated injections of morphine sulphate to non-obese and fatty Zucker rats.
    Thornhill JA; Saunders WS
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):477-85. PubMed ID: 6364234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel effects of the cannabinoid inverse agonist AM 251 on parameters related to metabolic syndrome in obese Zucker rats.
    Merroun I; Sánchez-González C; Martínez R; López-Chaves C; Porres JM; Aranda P; Llopis J; Galisteo M; Zarzuelo A; Errami M; López-Jurado M
    Metabolism; 2013 Nov; 62(11):1641-50. PubMed ID: 23932644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Opioid regulation of food intake and body weight in humans.
    Atkinson RL
    Fed Proc; 1987 Jan; 46(1):178-82. PubMed ID: 3542577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of moxonidine on feeding and body fat in obese Zucker rats: role of hypothalamic NPY neurones.
    Bing C; King P; Pickavance L; Brown M; Ziegler D; Kaan E; Williams G
    Br J Pharmacol; 1999 May; 127(1):35-42. PubMed ID: 10369453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Longer occupancy of opioid receptors by nalmefene compared to naloxone as measured in vivo by a dual-detector system.
    Kim S; Wagner HN; Villemagne VL; Kao PF; Dannals RF; Ravert HT; Joh T; Dixon RB; Civelek AC
    J Nucl Med; 1997 Nov; 38(11):1726-31. PubMed ID: 9374341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opioid receptor blockade promotes weight loss and improves the display of sexual behaviors in obese Zucker female rats.
    Marín-Bivens CL; Olster DH
    Pharmacol Biochem Behav; 1999 Jul; 63(3):515-20. PubMed ID: 10418795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of melatonin in vivo upon luteinizing hormone and prolactin releases induced by opiate receptor antagonists in adult male rats.
    Shacoori V; Saïag B; Lemay V; Girre A; Rault B
    J Endocrinol Invest; 1996 Feb; 19(2):76-82. PubMed ID: 8778169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regional brain glucose uptake in genetically diabetic C57BL/KsJ mice: modulation by the opiate antagonist, nalmefene.
    Garris DR; Michel ME
    Brain Res; 1988 Apr; 445(2):262-7. PubMed ID: 3370463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of the opioid antagonist LY255582 on body weight of the obese Zucker rat.
    Shaw WN; Mitch CH; Leander JD; Mendelsohn LG; Zimmerman DM
    Int J Obes; 1991 Jun; 15(6):387-95. PubMed ID: 1653188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of naloxone on food-motivated behavior in the obese Zucker rat.
    Glass MJ; O'Hare E; Cleary JP; Billington CJ; Levine AS
    Psychopharmacology (Berl); 1999 Feb; 141(4):378-84. PubMed ID: 10090645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. mu-receptor mediates elevated glucose and corticosterone after third ventricle injection of opioid peptides.
    Gunion MW; Rosenthal MJ; Morley JE; Miller S; Zib B; Butler B; Moore RD
    Am J Physiol; 1991 Jul; 261(1 Pt 2):R70-81. PubMed ID: 1677542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of naltrexone treatment on insulin secretion, insulin action and postprandial thermogenesis in obesity.
    Vettor R; Macor C; Rossi E; De Palo C; Ruggeri A; Cobelli C; Federspil G
    Horm Metab Res; 1994 Apr; 26(4):188-94. PubMed ID: 8082873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preferential effects of the cannabinoid CB1 receptor antagonist, SR 141716, on food intake and body weight gain of obese (fa/fa) compared to lean Zucker rats.
    Vickers SP; Webster LJ; Wyatt A; Dourish CT; Kennett GA
    Psychopharmacology (Berl); 2003 Apr; 167(1):103-11. PubMed ID: 12632249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of phenylpiperidine opioid antagonists on food consumption and weight gain of the obese Zucker rat.
    Shaw WN; Mitch CH; Leander JD; Zimmerman DM
    J Pharmacol Exp Ther; 1990 Apr; 253(1):85-9. PubMed ID: 2329525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modification of insulin resistance by diazoxide in obese Zucker rats.
    Alemzadeh R; Slonim AE; Zdanowicz MM; Maturo J
    Endocrinology; 1993 Aug; 133(2):705-12. PubMed ID: 8344209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Feeding behavior responses of Zucker rats to naloxone.
    McLaughlin CL; Baile CA
    Physiol Behav; 1984 May; 32(5):755-61. PubMed ID: 6494279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Behavioral effects of 6-methylene naltrexone (nalmefene) in rhesus monkeys.
    France CP; Gerak LR
    J Pharmacol Exp Ther; 1994 Sep; 270(3):992-9. PubMed ID: 7932212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.